title: Interferon-alpha-2b in the management of patients with relapsed and/or refractory Hodgkin's disease.
authors.forename: F
authors.initials: F
authors.lastname: Maloisel
authors.forename: L
authors.initials: L
authors.lastname: Voillat
authors.forename: M P
authors.initials: MP
authors.lastname: Chenard
authors.forename: A
authors.initials: A
authors.lastname: Boehn
authors.forename: B
authors.initials: B
authors.lastname: Lioure
authors.forename: F
authors.initials: F
authors.lastname: Oberling
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011994:Recombinant Proteins; D012008:Recurrence
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins